As of April 29, 2025, Rallybio (RLYB) has a market cap of $12.654 million USD. According to our data, Rallybio is ranked No.8747 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $12.65 M |
-68.23%
|
Dec 31, 2024 | $39.83 M |
-59.83%
|
Dec 29, 2023 | $99.16 M |
-63.62%
|
Dec 30, 2022 | $0.27 B |
-31.13%
|
Dec 31, 2021 | $0.40 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() BioMarin Pharmaceutical
BMRN
|
$12.13 B |
0.000 M
|
![]() USA
|
![]() Ultragenyx
RARE
|
$3.57 B |
0.000 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$127.64 B |
0.004 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.98 B |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.23 B |
-0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.85 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.34 M |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.47 B |
0.000 M
|
![]() USA
|
![]() Rocket Pharmaceuticals
RCKT
|
$0.78 B |
0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.98 B |
-0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$55.18 M |
0.000 M
|
![]() USA
|
Market Cap | = | RLYB Stock Price | * | RLYB Shares Outstanding |
= | $0.30 | * | 41.61 M | |
= | $12.65 M |